FI104968B - Förfarande för framställning av nya terapeutiskt aktiva substituerade imidazolderivat - Google Patents

Förfarande för framställning av nya terapeutiskt aktiva substituerade imidazolderivat Download PDF

Info

Publication number
FI104968B
FI104968B FI942882A FI942882A FI104968B FI 104968 B FI104968 B FI 104968B FI 942882 A FI942882 A FI 942882A FI 942882 A FI942882 A FI 942882A FI 104968 B FI104968 B FI 104968B
Authority
FI
Finland
Prior art keywords
dihydro
imidazole
compound
formula
inden
Prior art date
Application number
FI942882A
Other languages
English (en)
Finnish (fi)
Other versions
FI942882A0 (sv
FI942882A (sv
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Arja Leena Karjalainen
Maire Marjatta Eloranta
Antti Sakari Haapalinna
Jarmo Sakari Salonen
Hannu Tapani Sipilae
Original Assignee
Juvantia Pharma Ltd Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Juvantia Pharma Ltd Oy filed Critical Juvantia Pharma Ltd Oy
Priority to FI942882A priority Critical patent/FI104968B/sv
Publication of FI942882A0 publication Critical patent/FI942882A0/sv
Publication of FI942882A publication Critical patent/FI942882A/sv
Application granted granted Critical
Publication of FI104968B publication Critical patent/FI104968B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
FI942882A 1991-12-20 1994-06-16 Förfarande för framställning av nya terapeutiskt aktiva substituerade imidazolderivat FI104968B (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI942882A FI104968B (sv) 1991-12-20 1994-06-16 Förfarande för framställning av nya terapeutiskt aktiva substituerade imidazolderivat

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB919127050A GB9127050D0 (en) 1991-12-20 1991-12-20 Substituted imidazole derivatives and their preparation and use
GB9127050 1991-12-20
FI9200349 1992-12-18
PCT/FI1992/000349 WO1993013074A1 (en) 1991-12-20 1992-12-18 Substituted imidazole derivatives and their preparation and use
FI942882 1994-06-16
FI942882A FI104968B (sv) 1991-12-20 1994-06-16 Förfarande för framställning av nya terapeutiskt aktiva substituerade imidazolderivat

Publications (3)

Publication Number Publication Date
FI942882A0 FI942882A0 (sv) 1994-06-16
FI942882A FI942882A (sv) 1994-06-16
FI104968B true FI104968B (sv) 2000-05-15

Family

ID=10706581

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942882A FI104968B (sv) 1991-12-20 1994-06-16 Förfarande för framställning av nya terapeutiskt aktiva substituerade imidazolderivat

Country Status (17)

Country Link
US (1) US5498623A (sv)
EP (1) EP0618906B1 (sv)
JP (1) JP3276371B2 (sv)
AT (1) ATE165350T1 (sv)
AU (1) AU664584B2 (sv)
CA (1) CA2117305C (sv)
DE (1) DE69225240T2 (sv)
DK (1) DK0618906T3 (sv)
ES (1) ES2115046T3 (sv)
FI (1) FI104968B (sv)
GB (1) GB9127050D0 (sv)
HK (1) HK1008962A1 (sv)
HU (1) HU220043B (sv)
NO (1) NO304227B1 (sv)
PL (1) PL172532B1 (sv)
RU (1) RU2120440C1 (sv)
WO (1) WO1993013074A1 (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9312669D0 (en) * 1993-06-18 1993-08-04 Orion Yhtymae Oy New opticla isomers
FR2735776B1 (fr) * 1995-06-22 1997-07-18 Synthelabo Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
GB9520150D0 (en) 1995-10-03 1995-12-06 Orion Yhtymae Oy New imidazole derivatives
US20020143007A1 (en) * 1996-02-02 2002-10-03 Garvey David S. Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
US6388090B2 (en) 2000-01-14 2002-05-14 Orion Corporation Imidazole derivatives
FI20000073A0 (sv) * 2000-01-14 2000-01-14 Orion Yhtymae Oy Nya imidazol derivat
US8188126B2 (en) 2002-05-16 2012-05-29 Pierre Fabre Medicament Imidazolic compounds and use thereof as alpha-2 adrenergic receptors
FI20022007A0 (sv) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromucosal preparat och förfarande för framställning av detsamma
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
CN102548951A (zh) 2009-07-24 2012-07-04 帝斯曼医药化学雷根斯堡技术有限公司 作为中间体的二氢化茚衍生物
JP2013500983A (ja) * 2009-07-31 2013-01-10 ドクター・レディーズ・ラボラトリーズ・リミテッド フィパメゾールの調製
EP2502917A1 (en) 2011-03-17 2012-09-26 Santhera Pharmaceuticals (Schweiz) AG Solid state crystalline forms of 4-(2-ethyl-5-fluoro-2,3-dihydro-1H-inden-2-yl)-1H-imidazole
WO2017079734A1 (en) * 2015-11-05 2017-05-11 University Of Louisville Research Foundation, Inc. Local and regional anesthesia and analgesia

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1282535A (en) * 1970-03-02 1972-07-19 Pfizer (2-IMIDAZOLIN-2-YLAMINO)SUBSTITUTED BENZO[b]THIOPHENES
US3927023A (en) * 1974-05-24 1975-12-16 Warner Lambert Co Imidazolyl benzofurans
US3927018A (en) * 1974-12-23 1975-12-16 Sandoz Ag 3-(2-Methyl-1-imidazolyl)-3-phenyl-1-(3H)isobenzofuranones
IL66242A0 (en) * 1981-07-23 1982-11-30 Erba Farmitalia N-imidazolyl derivatives of 1,2,3,4-tetrahydro-naphthalene,indan and 2-substituted-1-chroman,their preparation and pharmaceutical compositions containing them
NZ201219A (en) * 1981-07-28 1984-10-19 Reckitt & Colmann Prod Ltd Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions
ES8503669A1 (es) * 1982-07-05 1985-03-01 Erba Farmitalia Procedimiento para preparar derivados n-imidazolilicos de compuestos biciclicos.
GB8409884D0 (en) * 1984-04-17 1984-05-31 Detexomat Machinery Ltd Transporting fabric pieces
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
FI81092C (sv) * 1986-05-15 1990-09-10 Farmos Oy Förfarande för framställning av terapeutiskt aktiva 4(5)-(2,3-dihydro- 1H-inden-2-yl)-imidazolderivat
JP2855341B2 (ja) * 1988-06-10 1999-02-10 武田薬品工業株式会社 新規２―置換クマラン誘導体
IL91542A0 (en) * 1988-10-06 1990-04-29 Erba Carlo Spa N-imidazolyl-and n-imidazolyl-methyl derivatives of substituted bicyclic compounds,their preparation and pharmaceutical compositions containing them
GB2225782A (en) * 1988-12-09 1990-06-13 Farmos Group Limited Imidazole derivatives useful for treatment of diabetes
GB9020128D0 (en) * 1990-09-14 1990-10-24 Reckitt & Colmann Prod Ltd Imidazoline derivatives
JP3050916B2 (ja) * 1991-12-23 2000-06-12 モービル・オイル・コーポレーション 酸素透過性の低いフィルム
GB9127430D0 (en) * 1991-12-27 1992-02-19 Scras Benzofuranylimidazole derivatives

Also Published As

Publication number Publication date
US5498623A (en) 1996-03-12
NO304227B1 (no) 1998-11-16
EP0618906B1 (en) 1998-04-22
RU94031215A (ru) 1996-04-20
ES2115046T3 (es) 1998-06-16
FI942882A0 (sv) 1994-06-16
DK0618906T3 (da) 1999-01-25
EP0618906A1 (en) 1994-10-12
PL172532B1 (en) 1997-10-31
HU9401823D0 (en) 1994-09-28
NO942335D0 (no) 1994-06-17
HU220043B (hu) 2001-10-28
ATE165350T1 (de) 1998-05-15
DE69225240T2 (de) 1998-08-27
DE69225240D1 (de) 1998-05-28
AU664584B2 (en) 1995-11-23
CA2117305C (en) 2003-11-25
FI942882A (sv) 1994-06-16
JPH07506087A (ja) 1995-07-06
HK1008962A1 (en) 1999-05-21
WO1993013074A1 (en) 1993-07-08
NO942335L (no) 1994-06-20
GB9127050D0 (en) 1992-02-19
CA2117305A1 (en) 1993-07-08
HUT67548A (en) 1995-04-28
JP3276371B2 (ja) 2002-04-22
AU3160593A (en) 1993-07-28
RU2120440C1 (ru) 1998-10-20

Similar Documents

Publication Publication Date Title
FI104968B (sv) Förfarande för framställning av nya terapeutiskt aktiva substituerade imidazolderivat
FR2501690A1 (fr) Derives heterocycliques du type 1,2,4-triazole, leur preparation et leur application pharmacologique
EP0833818A1 (fr) Composes agonistes du recepteur cb 2?
EP1149078B1 (en) Selective 5-ht 6 receptor ligands
JP2004517852A (ja) インドール誘導体および５−ｈｔ２ｂおよび５−ｈｔ２ｃ受容体リガンドとしてのそれらの使用
FR2551439A1 (fr) Agents antidepression a base de 1,2,4-triazol-3-one
HU197002B (en) Process for producing glutarimide derivatives
US6048862A (en) Benzylamidine derivatives with serotonin receptor binding activity
FI100242B (sv) Förfarande för framställning av nya terapeutiskt användbara pyrrolo£1, 2-a|pyratsinderivat
CA2246027A1 (en) Benzylamidine derivatives with serotonin receptor binding activity
US4782056A (en) 2-phenylhexahydro-1,2,4-triazine-3-,5-diones
US5925665A (en) Imidazoline compounds
EP2432766B1 (fr) Composé anticancéreux et composition pharmaceutique le contenant
JPH04273878A (ja) 複素環式化合物及びその製法
CZ291520B6 (cs) Nové deriváty 2,3-benzodiazepinu
Caroon et al. Structure-activity relationships for 2-substituted imidazoles as. alpha. 2-adrenoceptor antagonists
FR2744451A1 (fr) Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
FR2751647A1 (fr) Derives de benzimidazole, leurs preparations et leurs applications en therapeutique
CA2007401A1 (fr) Derives des bisarylalcenes, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
DK156396B (da) 2-(n-pyrrolidino)-3-isobutoxy-n-substituerede phenyl-n-benzyl-propylamin-forbindelser og farmaceutiske midler indeholdende disse
BG104988A (bg) N-бензодиоксанилметил-1-пиперидил-метиламин с афинитет към 5-нт рецептори
US3968230A (en) Compositions containing benzodiazepindiones and method of use
HU211271A9 (en) New optical isomers
GB2181731A (en) Fused bicyclic imides with psychotropic activity
HU211151A9 (hu) Szubsztituált imidazolszármazékok, előállításuk és alkalmazásuk

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: OY JUVANTIA PHARMA LTD.

GB Transfer or assigment of application

Owner name: OY JUVANTIA PHARMA LTD.

MA Patent expired